Authors
Latest:
IKA Keratoconus Symposium 2023: Strategies for early diagnosisAt the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.
Latest:
Keratoconus and perfect vision: Is it possible?Eye care providers must look beyond visual acuity in screening for disease.
Latest:
Children’s mental health and the impact of vision impairmentTwo studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
Latest:
IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&APresident and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
Latest:
Connecting the dots between the complement pathway and geographic atrophyCurrently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
Latest:
The tech savvy physician: How AI will transform your practiceInvestigators find technology aids instruction of medical students
Latest:
Femtosecond laser-assisted cataract surgery: One physician’s storyOphthalmologist outlines his journey with the procedure as a late adopter.
Latest:
BLOG: MicroPulse TLT for patients who struggle with dropsIn cases where patients struggle with applying or tolerating eye drops, especially after previous selective laser trabeculoplasty (SLT) treatment, MicroPulse transscleral laser therapy (TLT) offers a practical solution.
Latest:
Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucomaA recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.
Latest:
The truth about invisible posterior vitreous structuresThe advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.
Latest:
Pigskins and perception: How neuro-ophthalmology influences NFL refereesEvery football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Latest:
Treating traumatic brain injury neuro-optometricallyPhysicians note the impact of prism lenses can be life-changing for patients.
Latest:
MCO-010 optogenetic gene therapy for severe vision loss in Stargardt diseaseThe treatment option can have a positive impact on quality of life for patients.
Latest:
Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulasOlder generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
Latest:
Netarsudil provides IOP lowering in goniotomy treated eyesThe unique MOA may deliver a synergistic effect when prescribed post-surgically.
Latest:
Advancement in TED treatment is a bright spotFDA approval of teprotumumab as therapeutic offers hope for patients.
Latest:
Protecting cataract patients and their surgeons' practicesMaximizing refractive surgery is key to ensuring prosperous future
Latest:
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linkingJohn D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Latest:
ASRS 2024: Results of the LIGHTSITE III studyEleonora Lad, MD, PhD, spoke about her presentation, "Multiwavelength photobiomodulation significantly reduces risk for vision loss and onset of geographic atrophy in dry age-related macular degeneration" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Focusing on postinjection endophthalmitisSystemic immunosuppression may prevent devastating complication in patients.
Latest:
Seize underutilized opportunity to treat glaucoma during vitrectomyOphthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
